Warning: Potential Pancreatic Risks Linked to GLP-1 Weight Loss Injections Monday, November 24, 2025 glp1 tirzepatide semaglutide pancreatitis sideeffects weightloss nhs mhra medicationsafety yellowcard GLP-1 receptor agonists, such as tirzepatide (Mounjaro) and semaglutide (Wegovy), are popular injectable medications prescribed to support weight loss by reducing appetite and increasing feelings of fullness. Typically … Read More
Weight-loss jab Mounjaro outperforms rival Wegovy in major study Sunday, May 11, 2025 mounjaro wegovy weightloss obesity tirzepatide semaglutide clinicaltrial glp1 gip diabetes A groundbreaking study has found that the weight-loss drug Mounjaro (tirzepatide) helps patients lose significantly more weight than its competitor, Wegovy (semaglutide). Presented at the European Congress on Obesity in … Read More